Private Equity

Updated:

Bioprocess Capital Partners

Bioprocess Capital Partners is a Moscow-based private equity firm focused on early-stage venture.

Bioprocess Capital Partners logo

Bioprocess Capital Partners

BioProcess Capital Partners is the venture fund of BioProcess, a biotechnology company. It has made two investments. The firm invested in OncoTartis as part of their Series B on July 1, 2016.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

Europe

Country

Russia

City

Moscow

Corporate office

Moscow, Russia

Sector focus

Venture Capital

Frequently asked questions

What is Bioprocess Capital Partners?

Bioprocess Capital Partners is a private equity headquartered in Moscow, Russia.

Where is Bioprocess Capital Partners headquartered?

Bioprocess Capital Partners is headquartered in Moscow, Russia, in the Europe region.

What is Bioprocess Capital Partners's assets under management?

Bioprocess Capital Partners reports approximately Undisclosed in assets under management, as tracked by Altss.

What does Altss track for Bioprocess Capital Partners?

Altss maintains an OSINT-verified profile of Bioprocess Capital Partners covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.

What is Bioprocess Capital Partners's website?

Bioprocess Capital Partners's public website is www.bcvf.ru. Verified contact details for principals and decision-makers are available to Altss subscribers.

What type of firm is Bioprocess Capital Partners?

Bioprocess Capital Partners is classified by Altss as a Private Equity, operating from Russia within the Europe region.

How does Altss source intelligence on Bioprocess Capital Partners?

Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.

When was Bioprocess Capital Partners's Altss profile last updated?

Bioprocess Capital Partners's profile on Altss was last refreshed on June 3, 2026. Continuous updates are applied as new public information is verified.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Moscow Private Equity profiles